<s> backgroundimmunotherapy is the only potentially curative treatment for multiple sclerosis ( ms).methodsin this study, we investigated the immunogenicity of a recombinant human papillomavirus ( hpv ) vaccine, which is now in clinical use for the prevention and treatment of ms in children.resultsin our study, we found that the vaccine is able to induce a strong and long - lasting induction of anti - ms immunity in mice.<n> this was confirmed by the detection of ms antigen in the blood of healthy mice and by induction of ms antibody in ms - negative mice after administration of the vaccine.<n> furthermore, we showed that the vaccine does not induce ms in ms - positive mice, as previously reported.conclusionswe conclude that the hpv vaccine is a promising candidate for the treatment and prevention of ms in children.</s>